Martingale Asset Management’s Pacira BioSciences PCRX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2.46M	Buy	108,823 +40,621	+60%	+$903K	0.06%	296
2025 Q4	$1.77M	Sell	68,202 -10,495	-13%	-$250K	0.04%	350
2025 Q3	$2.03M	Buy	78,697 +14,204	+22%	+$349K	0.05%	312
2025 Q2	$1.54M	Buy	64,493 +32,009	+99%	+$807K	0.04%	364
2025 Q1	$807K	Buy	+32,484	New	+$778K	0.02%	508
2023 Q3	–	Sell	-6,507	Closed	-$261K	–	830
2023 Q2	$261K	Hold	6,507	–	–	0.01%	722
2023 Q1	$266K	Sell	6,507 -29,510	-82%	-$1.17M	0.01%	728
2022 Q4	$1.39M	Buy	36,017 +2,804	+8%	+$136K	0.03%	357
2022 Q3	$1.77M	Buy	33,213 +3,501	+12%	+$195K	0.04%	281
2022 Q2	$1.73M	Buy	29,712 +291	+1%	+$19.1K	0.03%	309
2022 Q1	$2.25M	Buy	29,421 +2,500	+9%	+$167K	0.03%	256
2021 Q4	$1.62M	Hold	26,921	–	–	0.02%	366
2021 Q3	$1.51M	Buy	26,921 +19,918	+284%	+$1.15M	0.02%	392
2021 Q2	$425K	Hold	7,003	–	–	﹤0.01%	636
2021 Q1	$491K	Sell	7,003 -1,600	-19%	-$114K	0.01%	613
2020 Q4	$515K	Sell	8,603 -9,214	-52%	-$540K	0.01%	604
2020 Q3	$1.07M	Sell	17,817 -9,405	-35%	-$546K	0.01%	615
2020 Q2	$1.43M	Hold	27,222	–	–	0.02%	636
2020 Q1	$913K	Buy	+27,222	New	+$1.13M	0.01%	706
2019 Q2	–	Sell	-29,721	Closed	-$1.13M	–	1051
2019 Q1	$1.13M	Sell	29,721 -498	-2%	-$19.4K	0.01%	755
2018 Q4	$1.3M	Buy	+30,219	New	+$1.41M	0.02%	641
2015 Q2	–	Sell	-2,300	Closed	-$205K	–	892
2015 Q1	$205K	Sell	2,300 -102	-4%	-$10.3K	﹤0.01%	839
2014 Q4	$213K	Sell	2,402 -5,802	-71%	-$549K	0.01%	816
2014 Q3	$796K	Buy	+8,204	New	+$798K	0.02%	567